Locate Bio Joins UK Biomaterials Innovators Addressing Unmet Orthopedic Surgery Needs
Since its September 2021 $13m (£10m) funding round, Locate Bio has continued the development of its range of orthobiologics focused on improving outcomes from orthopedic surgery.
You may also be interested in...
The Medicines and Medical Devices Act presses the UK to regulate in such a way that makes the market attractive for industry and investment. Medtech manufacturers insist the MHRA must strike the right balance as it brings its ‘plan for a new agency’ to life, said the ABHI’s Phil Brown, in the second of a two-part industry view of UK medtech’s regulatory future.
The money will be used to further clinical research for its innovative, drug releasing, bone grafting products.
Embecta, which recently completed its spin-off from Becton Dickinson, is forging ahead with its insulin injector-based business strategy, GLP-1s be damned.